Diabetes in a high secure hospital

Aims: To determine the prevalence of diabetes mellitus and its possible causes and to assess its control in a high secure hospital. Methods: A cross sectional survey and a prospective cohort study were conducted. The cross sectional survey included 408 patients admitted under the Mental Health Act, and the prospective study included 22 patients with known diabetes followed up for 24 months. The outcome measures evaluated were drug treatment, status of microvascular and macrovascular complications, glycated haemoglobin, and body mass index. Results: In the cross sectional survey, 35 out of 408 patients (8.6%; 95% confidence interval 5.9% to 11.3%) had known diabetes, and all of these had type 2 diabetes. Obesity, cigarette smoking, schizophrenia, and antipsychotic drug use were frequent, and weight gain was common after hospital admission. Glycaemic control was variable, and, although a majority of patients were above recommended treatment targets, control remained stable over the follow up period. Conclusions: Type 2 diabetes was common in this hospital. Both its prevalence and the suboptimal glycaemic control in some patients probably relate to sedentary life, dietary factors, smoking, and perhaps widespread use of antipsychotic drugs. However, regular multidisciplinary input enabled most patients to maintain relatively stable glycaemic control, with good control of blood pressure and lipids, at levels similar to those seen in community and hospital diabetic clinics. Further modification of lifestyle risk factors is probably needed to reduce the prevalence and impact of diabetes in this patient group.

[1]  D. Grobbee,et al.  Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus. , 2004, The Journal of clinical psychiatry.

[2]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[3]  E. Koller,et al.  Clozapine-associated diabetes. , 2001, The American journal of medicine.

[4]  K. Cruickshank,et al.  High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe? , 2001, Diabetes care.

[5]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[6]  C. Bogardus,et al.  Changing habits to delay diabetes. , 2001, The New England journal of medicine.

[7]  G. Tollefson,et al.  Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. , 2001, The Journal of clinical psychiatry.

[8]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[9]  H. Gin,et al.  Diabetes as a result of atypical anti‐psychotic drugs – a report of three cases , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[10]  D. Goff,et al.  Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. , 2000, The American journal of psychiatry.

[11]  N. Beeching,et al.  Capture-recapture-adjusted prevalence rates of type 2 diabetes are related to social deprivation. , 1999, QJM : monthly journal of the Association of Physicians.

[12]  S. Marder,et al.  Novel antipsychotics and new onset diabetes , 1998, Biological Psychiatry.

[13]  L. Nolan,et al.  Bodyweight Gain Induced by Psychotropic Drugs , 1998 .

[14]  J. Peters,et al.  NHS acute sector expenditure for diabetes: the present, future, and excess in‐patient cost of care , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[15]  J. Peters,et al.  Patterns of In and Out‐patient Activity for Diabetes: a District Survey , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[16]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[17]  E. Masson,et al.  An Audit of the Management and Outcome of Hospital Inpatients With Diabetes: Resource Planning Implications for the Diabetes Care Team , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[18]  E. Masson,et al.  Diabetes in prison: can good diabetic care be achieved? , 1992, BMJ.

[19]  C. Fraser,et al.  Problems of diabetics in prison , 1989, BMJ.

[20]  H. McKee,et al.  DIABETES AND SCHIZOPHRENIA—A PRELIMINARY STUDY , 1986, Journal of clinical and hospital pharmacy.

[21]  F. Brambilla,et al.  Glucose-insulin metabolism in chronic schizophrenia. , 1976, Diseases of the nervous system.

[22]  W. Lorenz SUGAR TOLERANCE IN DEMENTIA PRAECOX AND OTHER MENTAL DISORDERS , 1922 .

[23]  F. Kooy HYPERGLYÆMIA IN MENTAL DISORDERS , 1919 .

[24]  N. Sicolo,et al.  Effect of chlorpromazine on blood glucose and plasma insulin in man , 2004, European Journal of Clinical Pharmacology.

[25]  Anson,et al.  DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .

[26]  L. Dixon,et al.  Prevalence and correlates of diabetes in national schizophrenia samples. , 2000, Schizophrenia bulletin.

[27]  P. Decina,et al.  Diabetes mellitus in schizophrenic patients. , 1996, Comprehensive psychiatry.

[28]  P. Cowen,et al.  Practical problems in clinical psychiatry , 1992 .

[29]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.